Cargando…

Herbal pair Huangqin-Baishao: mechanisms underlying inflammatory bowel disease by combined system pharmacology and cell experiment approach

BACKGROUND: Inflammatory bowel disease (IBD) is a severe digestive system condition, characterized by chronic and relapsing inflammation of the gastrointestinal tract. Scutellaria baicalensis Georgi (Huangqin, HQ) and Paeonia lactiflora Pall (Baishao, BS) from a typical herbal synergic pair in tradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaoqi, Chen, Zhiwei, Li, Minyao, Zhang, Yaomin, Xu, Shijie, Huang, Haiyang, Wu, Xiaoli, Zheng, Xuebao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523401/ https://www.ncbi.nlm.nih.gov/pubmed/32988394 http://dx.doi.org/10.1186/s12906-020-03068-2

Ejemplares similares

A Network Pharmacology Approach to Explore the Potential Mechanisms of Huangqin-Baishao Herb Pair in Treatment of Cancer
por: Xu, Tian, et al.
Publicado: (2020)

Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response
por: Zou, Ying, et al.
Publicado: (2016)

Radix Scutellariae — Huangqin
por: Wagner, Hildebert, et al.
Publicado: (2011)

Mining and expression analysis of candidate genes involved in regulating the chilling requirement fulfillment of Paeonia lactiflora ‘Hang Baishao’
por: Zhang, Jiaping, et al.
Publicado: (2017)

Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis
por: Xu, Xiaomin, et al.
Publicado: (2022)

Systems Pharmacology Based Strategy for Q-Markers Discovery of HuangQin Decoction to Attenuate Intestinal Damage
por: Dai, Xiao-min, et al.
Publicado: (2018)

Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis
por: Wu, Yi, et al.
Publicado: (2022)

Huangqin-Tang and Ingredients in Modulating the Pathogenesis of Ulcerative Colitis
por: Wang, Chunyan, et al.
Publicado: (2017)

Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer
por: Li, Ying-Jie, et al.
Publicado: (2023)

Evaluation of Toxicity, Bacteriostatic, Analgesic, Anti-Inflammatory, and Antipyretic Activities of Huangqin-Honghua-Pugongying-Jinyinhua Extract
por: Ye, Dongyang, et al.
Publicado: (2021)

Huangqin flavonoid extraction for spinal cord injury in a rat model
por: Zhang, Qian, et al.
Publicado: (2018)

Effect of Huangqin Tang on Colonic Gene Expression in Rats with Ulcerative Colitis
por: Wang, Dunfang, et al.
Publicado: (2020)

Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology
por: Cui, Xuran, et al.
Publicado: (2023)

Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice
por: Chen, Gang, et al.
Publicado: (2016)

Chinese herbal compound Huangqin Qingrechubi capsule reduces lipid metabolism disorder and inflammatory response in gouty arthritis via the LncRNA H19/APN/PI3K/AKT cascade
por: Zhang, Xianheng, et al.
Publicado: (2023)

Huangqin-Tang Ameliorates TNBS-Induced Colitis by Regulating Effector and Regulatory CD4(+) T Cells
por: Zou, Ying, et al.
Publicado: (2015)

Herbal and plant therapy in patients with inflammatory bowel disease
por: Triantafyllidi, Aikaterini, et al.
Publicado: (2015)

Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction
por: Yang, Yang, et al.
Publicado: (2017)

Systematic Evaluation of Randomized Clinical Trials of Huangqin Tang in Combination with Mesalazine for Ulcerative Colitis
por: Pan, Chengyu, et al.
Publicado: (2022)

Synergistic Effect of Huangqin Decoction Combined Treatment With Radix Actinidiae chinensis on DSS and AOM-Induced Colorectal Cancer
por: Huang, Jianbo, et al.
Publicado: (2022)

Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway
por: Huang, Shaowei, et al.
Publicado: (2021)

San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo
por: Ma, Qinhai, et al.
Publicado: (2018)

Gegen huangqin huanglian decoction for children rotavirus enteritis: A protocol for systematic review and meta-analysis
por: Wu, Yifang, et al.
Publicado: (2020)

Large dosage Huangqin (Scutellaria) and Huanglian (Rhizoma Coptidis) for T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials
por: Huang, Xiaoying, et al.
Publicado: (2020)

Flavonoid profiling of a traditional Chinese medicine formula of Huangqin Tang using high performance liquid chromatography
por: Li, Tao, et al.
Publicado: (2016)

HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis
por: Wang, Xu, et al.
Publicado: (2017)

Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics
por: Cui, Dong-Ni, et al.
Publicado: (2017)

Huangqin Tang Interference With Colitis Associated Colorectal Cancer Through Regulation of Epithelial Mesenchymal Transition and Cell Cycle
por: Ma, Xuran, et al.
Publicado: (2022)

Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015)

A systems pharmacology model for inflammatory bowel disease
por: Balbas-Martinez, Violeta, et al.
Publicado: (2018)

Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
por: Yuan, Shuo, et al.
Publicado: (2022)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
por: Petric, Zvonimir, et al.
Publicado: (2022)

Exploring the Underlying Mechanism of Ren-Shen-Bai-Du Powder for Treating Inflammatory Bowel Disease Based on Network Pharmacology and Molecular Docking
por: Jin, Ni, et al.
Publicado: (2022)

Effect of Huangqin Tang on Urine Metabolic Profile in Rats with Ulcerative Colitis Based on UPLC-Q-Exactive Orbitrap MS
por: Wang, Dunfang, et al.
Publicado: (2020)

Influence of Huangqin Decoction on the immune function and fecal microbiome of chicks after experimental infection with Escherichia coli O78
por: Wang, Junyan, et al.
Publicado: (2022)

Role of Huangqin Decoction in Intestinal Homeostasis and Colon Carcinogenesis Based on “SREBP1 Cholesterol Metabolism Treg Cell Differentiation”
por: Zhou, Junde, et al.
Publicado: (2023)

Transcriptomics and experimental validation-based approach to understand the effect and mechanism of Huangqin tang interfeience with colitis associated colorectal cancer
por: Ma, Xuran, et al.
Publicado: (2023)

Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease
por: Ke, Ping, et al.
Publicado: (2017)

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: Lefevre, Pavine L C, et al.
Publicado: (2020)

Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties
por: Liu, Yao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vm6gatb88u64kgb2ib134rtvf